Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP1 | O94782 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | ABL1 | P00519 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14590563 | 0.95 | USP1 (0.32) | USP1 | |
| SCHEMBL13651770 | 0.89 | ABL1 (0.37) | USP1SMN1; SMN2ESR1ESR2ABL1 | |
| SCHEMBL4810156 | 0.87 | MAPT (0.38) | USP1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL14193820 | 0.86 | MEN1 (0.32) | USP1SMN1; SMN2ESR1ESR2MEN1 | |
| SCHEMBL13651822 | 0.86 | TDP1 (0.38) | USP1SIGMAR1MEN1KMT2AKDM4E | |
| SCHEMBL14223488 | 0.86 | ACACB (0.36) | USP1SMN1; SMN2ESR1ESR2MEN1 | |
| SCHEMBL14193793 | 0.84 | USP1 (0.34) | USP1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL14193806 | 0.84 | ABL1 (0.35) | ABL1 | |
| SCHEMBL14223480 | 0.83 | SIGMAR1 (0.33) | USP1SIGMAR1MEN1KMT2A | |
| SCHEMBL13651780 | 0.82 | POLB (0.42) | SMN1; SMN2MEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7950795-B2 | Image forming method and ink-jet recording device utilizing photo-curable ink, and inkset, ink-jet recording method and ink-jet recording device utilizing photo-curable ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7950795-B2 | Image forming method and ink-jet recording device utilizing photo-curable ink, and inkset, ink-jet recording method and ink-jet recording device utilizing photo-curable ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090252895-A1 | Actinic ray curable composition, actinic ray curable ink and image formation method employing the ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-7473718-B2 | Actinic ray curable composition, and actinic ray curable ink and image forming method by use thereof | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-01-06 | — | — | US | disclosed |
| US-7473718-B2 | Actinic ray curable composition, and actinic ray curable ink and image forming method by use thereof | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2009-01-06 | — | — | US | disclosed |
| US-7455887-B2 | Actinic ray curable ink-jet ink composition, image formation method employing the same, and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC INC. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-7455887-B2 | Actinic ray curable ink-jet ink composition, image formation method employing the same, and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC INC. (JP) | 2008-11-25 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1840148-A1 | POLYMERIZABLE ACTINIC RADIATION CURABLE COMPOSITION, POLYMERIZATION METHOD, ACTINIC RADIATION CURABLE INK AND IMAGE FORMATION METHOD, AND INK JET RECORDING APPARATUS AND EPOXY COMPOUND | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-10-03 | — | — | EP | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070219292-A1 | INK SET FOR INK-JET RECORDING, POLYMERIZATION METHOD AND IMAGE FORMING METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1829936-A1 | ACTIVE RAY-CURABLE COMPOSITION, ACTIVE RAY-CURABLE INK AND IMAGE-FORMING METHOD | Konica Minolta Medical & Graphic, Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-7169446-B2 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-30 | — | — | US | disclosed |
| US-7169446-B2 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107821-A1 | Polymerizable Actinic Radiation Curable Composition, Polymerization Method, Actinic Radiation Curable Ink and Image Formation Method, and Ink Jet Recording Apparatus and Epoxy Compound | CBR3, CBR1, CNR1 | USP1 708/4885SMN1; SMN2 2056/4885ESR1 1069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.